Market Analysis and Insights: Global Nuclear Cardiology Market
Nuclear imaging in cardiac disorders aids in accurate diagnosis of cardiovascular diseases and blockages in blood flow. Nuclear imaging is a technique for producing images of various body parts utilizing radioactive materials. This technique has applications in diagnosis of various cardiovascular diseases such as angina, aneurysm, atherosclerosis, stroke, coronary artery disease and congestive heart failure. Accurate diagnosis of such chronic diseases is essential to plan precise and cost-effective therapeutic module.
The global Nuclear Cardiology market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Geographically, this market is categorized into North America, Europe, Asia-Pacific and Rest of the World. Better capacities to handle new and highly advanced technologies have kept North America ahead of the other regions in terms of the nuclear cardiology market. However, catering to the untapped opportunities in the Asia-Pacific and Latin American regions will drive these regions at a faster growth rate.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nuclear Cardiology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nuclear Cardiology market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nuclear Cardiology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nuclear Cardiology market.
Global Nuclear Cardiology Scope and Market Size
Nuclear Cardiology market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Nuclear Cardiology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Radiology Devices
Radiology Information Systems (RIS)
Radiopharmaceuticals
Segment by Application
Hospitals
Clinics
Academic and Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GE Healthcare
Shimadzu
Siemens Healthcare
Fujifilm Medical
Astellas Pharma
Philips Healthcare
Medtronic
3mensio Medical Imaging
Bracco Diagnostics
UltraSPECT